Office of Inclusion and Diversity

Recruit, Retain, Reaffirm

  • Love banner
  • Ben Franklin
  • Students
  • Campus
  • Students
  • Students

Welcome to Penn Medicine's Office of Inclusion and Diversity

Eve J. HigginbothamLasting commitment is born of genuine appreciation for that which we aspire to be.  Penn Medicine’s commitment to inclusion and diversity is more than words echoing our evolving society; it is a commitment backed by actions that are the foundation of our eminence, core values, and the strategic priorities that drive how we discover, educate, and serve the world.

Penn Medicine’s five-year strategic plan 2013-2017, Shaping the Future of Medicine, defined our priorities; one of which was the creation of the Office of Inclusion and Diversity (OID).  Our efforts are aimed at supporting the many innovative programs underway, as well as exploring new opportunities to embrace diversity and broaden access to people of all ethnicities, historical traditions and economic backgrounds, genders, religions and disabilities, and respecting sexual orientation and veteran status.  I urge you to visit our site often and let us share in this commitment with you.

To learn more about the OID and its initiatives review our current annual report, our first annual report, and our fifth anniversary annual report

If you would like to help support OID's Mission, donate here

Watch the 2018 Dr. Martin Luther King Jr. Health Equity Symposium here!

We would like to thank everyone who joined us for Health Equity Week, April 3rd through April 7th.  We would also like to congratulate those who won awards at the Health Equity Poster Session, who can be found along with links to their posters here. 



BLOG: Conversations About Inclusion and Diversity

Penn LDI: Koh Promotes Partnerships at Penn 2018 Health Equity Symposium

Collaborating across public and private sectors

Read full article | Go to blog

Funding Opportunities

  • PA-18-658

    Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)

  • PAR-18-612

    Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research

  • PAR-18-611

    Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research

Upcoming Events